Founder, Taurus 3D, Technical Director, Medical Makers, & Project Manager, 3D4MD
Saving Lives Time and Money Using 3D Printing, Drones, Robotics, and Telemedicine
Jerry Ennett is the founder of 3D printing start-up Taurus 3D, the Technical Director of Medical Makers, and a Project Manager at 3D4MD. Over the past 3 years he has been working with patients to improve their lives using 3D printing. He was recently awarded the Grand Prize at the 2016 World Vision Social Innovation Challenge and is taking 3D printing to multiple hospitals in Ghana. At Medical Makers he trains and manages projects that involve their global team of engineers, students, designers, and other professionals in order to save lives, time, and money using advanced technologies. In this talk, Jerry will highlight his experience and some of the most impactful projects he has worked on, including how he helped design the first medical supplies to be 3D printed on the International Space Station. He will also talk about how you can get involved with Medical Makers and help real patients using technology.
Systems change consultant at Reos Partners, Co-founder of Journey CX
What’s Your Problem?! – Tackling challenges in complex healthcare systems
Jessica is recognized as one of Canada’s next high impact entrepreneurs. She is a systems change consultant at Reos Partners, and co-founder of the innovation consultancy Journey CX. She works closely with systems leaders to address complex social challenges through organizational culture change, lean start-up methodologies, and human-centred design.
Previously, Jessica founded two language technology companies with over 1 million users, and has worked within leading-edge organizations including Google and Adaptive Path. Her projects have spanned multiple sectors including international development, financial services, sustainable agriculture, and consumer technology.
Jessica is a Next 36 alum, former Engineers Without Borders chapter president, and studied an eclectic mix of biomedical chemical engineering, interaction design, and business.
PhD Candidate in Drinking Water Research Group, University of Toronto
Improving Access to Clean and Safe Drinking Water Through Technology
Stephanie Gora is a PhD candidate with the Drinking Water Research Group at the University of Toronto. Her research focuses on the incorporation of engineered titanium dioxide nanomaterials into drinking water treatment processes to enhance treatment efficiency and sustainability. From April 2009 until August 2012 Stephanie worked as a process engineer at CBCL Limited in Halifax, Nova Scotia.
Dr. Axel Guenther
Associate Professor, Department of Mechanical and Industrial Engineering, Institute of Biomaterials and Biomedical Engineering, University of Toronto
From 3D-Bioprinting of Planar and Ductular Materials Towards Solving Problems
Dr. Guenther is an Associate Professor in the Department of Mechanical and Industrial Engineering, with cross-appointment at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. He obtained his doctoral degree from the Swiss Federal Institute of Technology (ETH) in Zurich and conducted postdoctoral research at the Massachusetts Institute of Technology. He is recipient of the ETH medal (2002), the Ontario Early Researcher Award (2009), the I.W. Smith Award of the Canadian Society of Mechanical Engineers (2010) and the Innovator of the Year Award of the University of Toronto (2013). He co-invented several bioprinting technologies, currently serves as the Scientific Director of the Centre for Microfluidic Systems in Chemistry and Biology in Toronto, and holds the Wallace G. Chalmers Chair of Engineering Design.
Program manager for the Innovation Partnership: Procurement by Co-Design program at MaRS
Designing a better healthcare experience: A quick intro
Lily manages the Procurement by Co-Design challenges to ensure effective collaboration between healthcare providers and vendors. Lily joined MaRS in 2013, after graduating from the University of Waterloo with a BA in English Rhetoric and Business. She started her career at MaRS as the Associate for the EXCITE program, a world-first health technology evaluation program that brings together health technology innovators, health system payers, government and academia to foster the adoption of disruptive health technologies. In addition to working on EXCITE, Lily was the project manager for numerous health innovation showcases, including the Redefining Early Stage Investments Conference (RESI on MaRS), which drew hundreds of early-stage life science investors from the US, Asia, and Europe and featured the third-annual MaRS HealthKick pitch competition. Lily’s interest in technology developed during her time as an intern at BlackBerry, Sybase, Microsoft and eHealth Ontario.
Dr. Keith Pardee
Assistant Professor, Leslie Dan Faculty of Pharmacy, University of Toronto
Cell-free Synthetic Biology in Human Health
Our lab works in the field of synthetic biology and is pioneering the new in vitro devices branch of the field, which creates biomolecular devices outside of cells. Though these efforts we are using the cell-free platform to lower the cost and technical barriers to sensor development, and are producing new biotechnologies that can be embedded into handheld portable devices. This technology has been demonstrated with small-molecule and RNA actuation of genetic switches, and with programmable, paper-based in vitro diagnostics, including antibiotic resistance and strain-specific Zika virus sensors. In addition to molecular sensors, we have also developed a platform for the portable manufacture of protein-based therapeutics (e.g. vaccines, conjugated antibodies) for global health applications. Our lab continues to expand its efforts in cell-free synthetic biology and is working toward new foundational technologies.
Mech 1T9, Dept. Mechanical & Industrial Engineering, University of Toronto
Dual Purpose Condensers to provide potable water
During his junior and high school years, Calvin focused on developing passive systems to provide clean water where it is most acutely needed. He has received awards for this work at regional, national and international science fairs in several categories including engineering innovation, sustainability and environmental management. He has been named one of Canada’s Top 20 Under 20 and was a speaker at the 2016 TEDx Toronto Conference. Calvin is a member of the World Youth Parliament for Water, which raises awareness and promotes universal access to water and sanitation. He is studying Mechanical Engineering at University of Toronto.
Co-founder of Hacking Health, Program manager for the Innovation Partnership: Procurement by Co-Design program at MaRS, Manager of Health Ecosystems Partnerships at MaRS
Designing a better healthcare experience: A quick intro
Hadi is a co-founder of Hacking Health, a global non-profit that catalyzes collaboration between the health and tech/design communities to create prototypes to pressing health challenges. Hadi is also Program Manager for the Innovation Partnership: Procurement by Co-Design program at MaRS. He is also Manager, Health Ecosystem Partnerships at MaRS, responsible for developing relationships with forward-thinking healthcare delivery organizations. His role is to match partners with innovative startups and SMEs to co-design, test, pilot and validate leading-edge health technologies, accelerating the adoption of such technologies by the healthcare system. Finally, Hadi is co-founder of Hacking Health, growing a movement of innovators and co-creators to over 60 cities globally.
Dr. Emily Titus
Director, Technology Development, Centre for Commercialization of Regenerative Medicine
Maximizing Outcomes from Academic Discoveries in Regenerative Medicine
Emily is Director, Technology Development in the Advance labs at CCRM, with a focus on cell reprogramming, genome engineering and pluripotent stem cell differentiation. She obtained her PhD from the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, where she used a combination of laboratory and bioinformatics approaches to define and interpret gene regulatory networks controlling embryonic stem cell fate decisions. At CCRM, Emily’s team develops and evaluates technology related to iPSC derivation, genome engineering, directed differentiation, translation of bench scale protocols to scalable platforms, and works on projects that advance the commercialization of stem cells.